论文部分内容阅读
目的 :探讨肝动脉化疗栓塞在治疗复发性肝癌中的价值。方法 :应用超液化碘油及常规化疗药物 ,经股动脉穿刺插管 (2 3例 )及经皮下带囊导管 (17例 )行肝动脉化疗栓塞治疗 40例复发性肝癌。平均治疗 2 .3次。结果 :1,2 ,3年生存率 (直接法 )分别为 78.4% ,45 .7% ,2 4.2 %。与同期行肿瘤切除及其它治疗病例相比 ,生存率低于肿瘤切除病例 ,高于其它治疗病例 (经Gehan比分检验 ,u =3 77及 4.19,P <0 .0 1)。结论 :肝动脉栓塞化疗是不能切除的复发性肝癌的有效治疗方法 ,能明显提高患者生存率。
Objective: To investigate the value of transcatheter arterial chemoembolization in the treatment of recurrent hepatocellular carcinoma. Methods: 40 cases of recurrent hepatocellular carcinoma (HCC) were treated with transcatheter arterial chemoembolization via perfusion of lipiodol and conventional chemotherapeutic drugs via femoral artery puncture and intubation (23 cases) and transdermal catheterization (17 cases). The average treatment of 2.3 times. Results: The 1, 2, 3 year survival rates (direct method) were 78.4%, 45.7% and 22.2% respectively. Survival rate was lower than that of tumor resection and other treatment cases (P <0.01 by Gehan score, u = 3 77 and 4.19, respectively) compared with resection of tumor and other treatment in the same period. Conclusion: Hepatic arterial chemoembolization is an effective treatment for unresectable recurrent hepatocellular carcinoma, which can significantly improve the survival rate of patients.